These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 17167954)

  • 21. [Success rate in patients with lung TB registered in Braşov county between 1990 and 2001].
    Macavei C
    Pneumologia; 2003; 52(2):99-110. PubMed ID: 14702713
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Antituberculous retreatement in case of failure to category I regimen].
    Horo K; Koffi NB; Kouassi BA; Brou-Godé VC; Ahui BJ; Silué Y; Touré K; Gnazé ZA; Kouakou KM; N'gom A; Aka-Danguy E
    Rev Mal Respir; 2010 Nov; 27(9):1055-61. PubMed ID: 21111276
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Category based treatment of tuberculosis in children.
    Kabra SK; Lodha R; Seth V
    Indian Pediatr; 2004 Sep; 41(9):927-37. PubMed ID: 15475636
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Study of relapse and failure cases of CAT I retreated with CAT II under RNTCP--an eleven year follow up.
    Mehra RK; Dhingra VK; Nish A; Vashist RP
    Indian J Tuberc; 2008 Oct; 55(4):188-91. PubMed ID: 19295105
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk factors for tuberculosis treatment failure, default, or relapse and outcomes of retreatment in Morocco.
    Dooley KE; Lahlou O; Ghali I; Knudsen J; Elmessaoudi MD; Cherkaoui I; El Aouad R
    BMC Public Health; 2011 Feb; 11():140. PubMed ID: 21356062
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Resistance and efficacy of treatment in relapse pulmonary tuberculosis].
    Tu D; Zhang L; Su J
    Zhonghua Jie He He Hu Xi Za Zhi; 2000 Nov; 23(11):666-8. PubMed ID: 11225030
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Representative drug susceptibility patterns for guiding design of re-treatment regimens for multidrug-resistant tuberculosis in Iran.
    Tabarsi P; Nooraki A; Mirsaeidi M; Amiri M; Baghaei P; Farnia P; Kazempour M; Heidarnazhad H; Alipanah N; Mansouri D; Masjedi MR
    Respirology; 2008 Jan; 13(1):108-11. PubMed ID: 18197919
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment interruptions and duration associated with default among new patients with tuberculosis in six regions of Russia.
    Jakubowiak W; Bogorodskaya E; Borisov S; Danilova I; Kourbatova E
    Int J Infect Dis; 2009 May; 13(3):362-8. PubMed ID: 19008141
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment outcomes of new and previously-treated smear positive pulmonary tuberculosis at Srinagarind Hospital, a tertiary care center in northeast Thailand.
    Reechaipichitkul W; So-Ngern A; Chaimanee P
    J Med Assoc Thai; 2014 May; 97(5):490-9. PubMed ID: 25065087
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High success rate of TB treatment among Bhutanese refugees in Nepal.
    Bam TS; Enarson DA; Hinderaker SG; Chapman RS
    Int J Tuberc Lung Dis; 2007 Jan; 11(1):54-8. PubMed ID: 17217130
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [A-cohort study on the standard short-course chemotherapy program for drug resistant tuberculosis in the rural counties in Eastern China].
    Hu Y; Jiang WL; Wang WB; Xu B
    Zhonghua Liu Xing Bing Xue Za Zhi; 2008 Jun; 29(6):540-4. PubMed ID: 19040032
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk of relapse and failure after retreatment with the Category II regimen in Nepal.
    Yoshiyama T; Shrestha B; Maharjan B
    Int J Tuberc Lung Dis; 2010 Nov; 14(11):1418-23. PubMed ID: 20937181
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Improved cure rates in pulmonary tuberculosis category II (retreatment) with mycobacterium w.
    Patel N; Trapathi SB
    J Indian Med Assoc; 2003 Nov; 101(11):680, 682. PubMed ID: 15198421
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mortality and failure among tuberculosis patients who did not complete treatment in Vietnam: a cohort study.
    Vree M; Huong NT; Duong BD; Sy DN; Van le N; Co NV; Cobelens FG; Borgdorff MW
    BMC Public Health; 2007 Jul; 7():134. PubMed ID: 17605770
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect on tuberculosis outcomes of educational outreach to South African clinics during two randomised trials.
    Bachmann MO; Fairall LR; Lombard C; Timmerman V; van der Merwe S; Bateman ED; Zwarenstein M
    Int J Tuberc Lung Dis; 2010 Mar; 14(3):311-7. PubMed ID: 20132622
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Contributions of culture and antimicrobial susceptibility tests to the retreatment of patients with pulmonary tuberculosis.
    Andrade BH; Greco DB; Oliveira MT; Lacerda NP; Côrrea Rde A
    Rev Soc Bras Med Trop; 2013; 46(4):441-6. PubMed ID: 23970311
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk factors associated with default among new pulmonary TB patients and social support in six Russian regions.
    Jakubowiak WM; Bogorodskaya EM; Borisov SE; Danilova ID; Kourbatova EV
    Int J Tuberc Lung Dis; 2007 Jan; 11(1):46-53. PubMed ID: 17217129
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Results of therapy in pulmonary tuberculosis: outcome monitoring in northern Lower Saxony].
    Menke B; Sommerwerck D; Schaberg T
    Pneumologie; 2000 Feb; 54(2):92-6. PubMed ID: 10731763
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Survival and relapse rate of tuberculosis patients who successfully completed treatment in Vietnam.
    Vree M; Huong NT; Duong BD; Sy DN; Van LN; Hung NV; Co NV; Borgdorff MW; Cobelens FG
    Int J Tuberc Lung Dis; 2007 Apr; 11(4):392-7. PubMed ID: 17394684
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Two-year follow-up of directly-observed intermittent regimens for smear-positive pulmonary tuberculosis in China.
    Cao JP; Zhang LY; Zhu JQ; Chin DP
    Int J Tuberc Lung Dis; 1998 May; 2(5):360-4. PubMed ID: 9613630
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.